Filing Details

Accession Number:
0001062993-15-000243
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-20 20:12:04
Reporting Period:
2015-01-16
Filing Date:
2015-01-20
Accepted Time:
2015-01-20 20:12:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875622 Biospecifics Technologies Corp BSTC Pharmaceutical Preparations (2834) 113054851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1375378 Paul Gitman C/O Biospecifics Technologies Corp.
35 Wilbur Street
Lynbrook NY 11563
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Disposition 2015-01-16 4,113 $41.00 62,712 No 4 S Direct
Common Stock, $0.001 Par Value Acquisiton 2015-01-20 4,113 $1.00 66,825 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.001 Par Value Stock Option (Right to Buy) Disposition 2015-01-20 4,113 $0.00 5,887 $1.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,887 2006-01-23 2016-01-22 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2014.